Recombinant vaccines for COVID-19

SARS-CoV-2, the causative agent of COVID-19, has imposed a major public health threat, which needs effective therapeutics and vaccination strategies. Several potential candidate vaccines being rapidly developed are in clinical evaluation. Considering the crucial role of SARS-CoV-2 spike (S) glycopro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human vaccines & immunotherapeutics 2020-12, Vol.16 (12), p.2905-2912
Hauptverfasser:	Yadav, Tushar, Srivastava, Nishant, Mishra, Gourav, Dhama, Kuldeep, Kumar, Swatantra, Puri, Bipin, Saxena, Shailendra K
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 COVID-19 - genetics COVID-19 - metabolism COVID-19 - prevention & control COVID-19 Vaccines - genetics COVID-19 Vaccines - metabolism COVID-19 Vaccines - therapeutic use efficacy and safety Genetic Vectors - genetics Genetic Vectors - metabolism Genetic Vectors - therapeutic use Humans Mini Review recombinant vaccine SARS-CoV-2 Spike Glycoprotein, Coronavirus - genetics Spike Glycoprotein, Coronavirus - metabolism vaccine Vaccines, Synthetic - metabolism Vaccines, Synthetic - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!